ArticleBMC cancer2015

A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities.

Youzhi Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.